top of page

OUR DRUG PIPELINE

Promising disease product candidates for difficult to treat diseases

Website Pipeline 2023.jpg

UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransferase
(DPAGT1)

Email us at info@anviron.com to request more information including our White Paper for Trastuzumab resistant, Her2+ breast cancers.

CALL

Tel: +1 (949) 385-2233

EMAIL

LOCATION

Newport Beach, California USA

"We shall make good medicine here."

  • Twitter

 Proudly created with Wix.com

bottom of page